Wei-yu R. Liao
Hsinchu Science Park
Hsinchu, TNQ 30076, Taiwan
Hsinchu, TNQ 30076, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Response to the comment on "Real-world analysis of survival outcomes in advanced EGFR-mutant NSCLC patients treated with platinum-pemetrexed after EGFR-TKI failure".
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: December 20, 2025
Response to comment on "Real-world analysis of survival outcomes in advanced EGFR-mutant NSCLC patients treated with platinum-pemetrexed after EGFR-TKI failure".
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: November 30, 2025
A 3D Cell Culture Platform for Evaluating Macrophage-Liposome Conjugates in Combination Chemotherapy.
Journal: Journal of biomedical materials research. Part A
Published: February 02, 2025
Enhanced detection of actionable mutations in NSCLC through pleural effusion cell-free DNA sequencing: A prospective study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 11, 2024
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis.
Journal: Clinical and translational medicine
Published: September 22, 2024
Hope and its relationship with treatment/ physical related factors in lung cancer patients receiving immunotherapy.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: June 07, 2024
PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational study.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: May 05, 2024
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis.
Journal: Neoplasia (New York, N.Y.)
Published: April 23, 2024
Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan.
Journal: JCO precision oncology
Published: January 08, 2024
Lung adenocarcinoma with EGFR L858R-K860I and L858R-L861F doublet mutations from which the L858R mutation is undetectable through the cobas EGFR mutation test v2.
Journal: Pathology, research and practice
Published: November 25, 2023
Real-world analysis of survival outcomes in advanced EGFR-mutant NSCLC patients treated with platinum-pemetrexed after EGFR-TKI treatment failure.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: November 12, 2023
Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer.
Journal: Cancer medicine
Published: September 22, 2023
Last Updated: 09/26/2026